Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of age on outcome with primary angioplasty versus thrombolysis.
Holmes DR Jr, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Holmes DR Jr, et al. Among authors: pieper ks. J Am Coll Cardiol. 1999 Feb;33(2):412-9. doi: 10.1016/s0735-1097(98)00579-8. J Am Coll Cardiol. 1999. PMID: 9973021 Free article. Clinical Trial.
Directional atherectomy versus balloon angioplasty for coronary ostial and nonostial left anterior descending coronary artery lesions: results from a randomized multicenter trial. The CAVEAT-I investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
Boehrer JD, Ellis SG, Pieper K, Holmes DR, Keeler GP, Debowey D, Chapekis AT, Leya F, Mooney MR, Gottlieb RS, et al. Boehrer JD, et al. J Am Coll Cardiol. 1995 May;25(6):1380-6. doi: 10.1016/0735-1097(95)00008-r. J Am Coll Cardiol. 1995. PMID: 7722137 Free article. Clinical Trial.
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators.
Omoigui NA, Silver MJ, Rybicki LA, Rosenthal M, Berdan LG, Pieper K, King SV, Califf RM, Topol EJ. Omoigui NA, et al. J Am Coll Cardiol. 1998 Feb;31(2):265-72. doi: 10.1016/s0735-1097(97)00498-1. J Am Coll Cardiol. 1998. PMID: 9462565 Free article. Clinical Trial.
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Granger CB, Becker R, Tracy RP, Califf RM, Topol EJ, Pieper KS, Ross AM, Roth S, Lambrew C, Bovill EG. Granger CB, et al. Among authors: pieper ks. J Am Coll Cardiol. 1998 Mar 1;31(3):497-505. doi: 10.1016/s0735-1097(97)00539-1. J Am Coll Cardiol. 1998. PMID: 9502626 Free article. Clinical Trial.
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Cohen M, Mahaffey KW, Pieper K, Pollack CV Jr, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ; SYNERGY Trial Investigators. Cohen M, et al. J Am Coll Cardiol. 2006 Oct 3;48(7):1346-54. doi: 10.1016/j.jacc.2006.05.058. Epub 2006 Sep 12. J Am Coll Cardiol. 2006. PMID: 17010793 Free article. Clinical Trial.
272 results